Hear how Marken is rising to constant global disruptions — embracing innovation, reducing risk, and building future-ready solutions that balance speed, cost, and control.

Life sciences companies are accelerating digital transformation while maintaining regulatory compliance. Assurea explains how AI, integrated quality systems and analytics are reshaping the industry.

One of the biggest hurdles sponsors face is finding a CDMO with true commercial AAV experience—partners who have successfully taken them through global approvals into the commercial market.

GeminiBio and Tolemy Bio will introduce aiMOS™, an AI-driven media optimization service that helps teams reduce variability, increase performance, and improve manufacturability.

Limula is addressing the challenges of clinical centres and biotech companies looking for a solution enabling fully automated production of cell therapies at the point-of-care.

As a cell therapy advances to commercial-scale manufacturing, success depends on strategic partnerships that ensure quality, consistency, and regulatory compliance while enabling scalability.

In a complex, volatile global market, manufacturability is no longer something to address “when the time comes”-it must be built into the therapy from day one

CaseBioscience focuses on preservation of cells for storage and transport, so cell therapy developers have a partner for this crucial aspect of the cell therapy workflow.

NKILT Therapeutics brings a novel off-the-shelf cell therapy to tackle over half of cancers across hematologic and solid tumors.